Meanwhile, it appears relevant to screen for toxic tcDNA candidates in vitro by measuring activated P-selectin and glycoprotein IIb/IIIa, especially since thrombocytopenia is a known safety concern in preclinical and clinical ASO development.24 Here, SELP is linked to Thrombocytopenia.